Declaration of Dividend @Re. 1/- perv share (10%) for the financial year 2024-25 subject to the approval of the shareholders at the forthcoming Annual General Meeting.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 18.6 pts more than Nifty Microcap 250 and 18.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resonance Specialties reported a strong FY25 with revenue from operations rising to Rs. 7,780.66 lakhs from Rs. 5,530.09 lakhs in FY24, a growth of around 41%. Profit after tax jumped to Rs. 656.62 lakhs from Rs. 296.84 lakhs, more than doubling year-on-year, while EPS improved to Rs. 5.65 from Rs. 2.56. Q4 alone saw revenue of Rs. 2,420.17 lakhs (up about 48% YoY) and PAT of Rs. 305.75 lakhs (up over 350% YoY). The Board has recommended a dividend of Re. 1 per share (10% on face value of Rs. 10) with a record date of July 29, 2025, subject to shareholder approval. Statutory auditors Kailash Chand Jain & Co. issued an unmodified (clean) opinion on the financials.
Strong topline and earnings growth, supported by export revenue and higher India sales, signals improving business momentum and is positive for shareholders. The 10% dividend is a modest but welcome return, though investors should note that operating cash flow turned negative in FY25 due to a sharp rise in trade receivables and inventory build-up.